AstraZeneca Confirms Executive Vice President Leon Wang’s Detention in China
AstraZeneca Inc., (AZ, NASDAQ: AZN), a leading UK pharmaceutical company, has provided an update to...
Jiangsu Kanion Pharmaceutical to Acquire Xintrum Pharmaceuticals for RMB 270 Million
Jiangsu Kanion Pharmaceutical Co., Ltd (SHA: 600557), a China-based pharmaceutical company, has announced its intention...
Ascletis Pharma’s ASC47 Showcases Promising Weight Loss Results in Phase I Clinical Trial
Ascletis Pharma Inc. (HKG: 1672), a China-based pharmaceutical company, has announced positive results from a...
Nuwacell Biotechnologies Secures RMB150 Million in Series B Financing for iPSC Therapies
Nuwacell Biotechnologies Co., Ltd., a specialist in induced pluripotent stem cell (iPSC) technology based in...
Shanghai Henlius Biotech Partners with SVAX to Boost MENAT Region’s Access to Biological Drugs
Shanghai Henlius Biotech Inc. (HKG: 2696), a leading Chinese biotech company, has entered into a...
Johnson & Johnson MedTech’s Varipulse Platform Receives FDA Approval for Atrial Fibrillation Treatment
Johnson & Johnson MedTech (J&J, NYSE: JNJ) has announced that it has received marketing approval...
Sichuan Biokin Pharmaceutical Gets FDA Approval for Phase I Study of BL-M17D1 in Solid Tumors
Sichuan Biokin Pharmaceutical Co., Ltd (SHA: 688506), a China-based pharmaceutical company, has announced that it...
Bayer AG Receives FDA 510(k) Clearance for MEDRAD Centargo CT Injection System
Germany-based Bayer AG (ETR: BAYN) has announced that it has received 510(k) clearance from the...
Sichuan Huiyu Pharmaceutical’s HYP-6589 Receives NMPA Approval for Solid Tumor Clinical Trial
Sichuan Huiyu Pharmaceutical Co., Ltd (SHA: 688553), a China-based pharmaceutical company, has announced that it...
Ascentage Pharma’s Lisaftoclax and AceLink Therapeutics’ AL01211 Receive FDA Designations
The Center for Drug Evaluation (CDE) website has indicated that China-based Ascentage Pharma’s (HKG: 6855)...
AskBio’s AB-1003 Receives Rare Pediatric Disease and Orphan Drug Designations from FDA
Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned subsidiary of Bayer AG (ETR: BAYN), has announced...
Teva Pharmaceutical Expands Partnerships in China’s One Health Sector with New Agreements
Israel based Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has announced new partnerships with Chinese firms...
Bayer’s Leap Forward: Implementing Salesforce on Alibaba Cloud for Customer Engagement
Bayer (ETR: BAYN) has announced that its China Prescription Medicines business has fully adopted the...
CDE Releases Technical Guidelines for Pilot Registration and Phased Manufacturing of ADCs
The Center for Drug Evaluation (CDE) has issued the “Technical Requirements for Pilot Registration and...
Shanghai Pharmaceuticals’ MediTrust Health Partners with Eisai for Comprehensive Patient Services
Shanghai Pharmaceuticals Holding Co., Ltd’s (HKG: 2607, SHA: 601607) subsidiary, MediTrust Health, which specializes in...
Boehringer Ingelheim Partners with Wuhan Union Hospital to Enhance Clinical Research and Development
Boehringer Ingelheim, a leading German pharmaceutical company, has entered into a strategic partnership with Wuhan...
NHSA and MCA Boost Medical Assistance with Enhanced Information Sharing Measures
The National Healthcare Security Administration (NHSA) and the Ministry of Civil Affairs (MCA) have jointly...
Hainan Haiyao Enters JV with Haikou and Xenios AG to Advance ECMO Technology
Hainan Haiyao Co., Ltd (SHE: 000566), a prominent Chinese company, has announced the signing of...
Belief BioMed’s BBM-D101 Receives FDA Orphan Drug and Pediatric Rare Disease Designations for DMD
Belief BioMed has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan...
Nanjing Leads Biolabs and Aditum Bio Launch Oblenio Bio with Focus on CD19 Tri-Specific Antibody
China-based Nanjing Leads Biolabs Co., Ltd and venture capital firm Aditum Bio have announced the...